| Scorecard |
|---|
|
5 / 5 Stars
|
|
Lipper
5
5
5
5
3
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
A-
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 6.35 | 6.35 |
| Stocks | 79.84 | 79.84 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 13.82 | 13.82 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Roche Holding AG | RHHVF | 23.65 | 5.39 |
| Amgen Inc | AMGN | 21.82 | 4.61 |
| Johnson & Johnson | JNJ | 21.03 | 4.41 |
| Charles Schwab Corp | SCHW | 13.3 | 4.01 |
| Eli Lilly and Company | LLY | 10.97 | 3.76 |
| Texas Instruments, Inc. | TXN | 19.46 | 3.59 |
| Microsoft Corporation | MSFT | 23.36 | 2.82 |
| Novartis AG ADR | NVS | 18.86 | 2.64 |
| L Brands Inc | LTD | 7.18 | 2.49 |
| Medtronic, Inc. | MDT | 14.36 | 2.4 |
